Willis Lease (WLFC) Insider Notice: 30,000-Share Sale via Merrill Lynch
Rhea-AI Filing Summary
Willis Lease Finance Corp (WLFC) submitted a Form 144 reporting a proposed sale of 30,000 common shares acquired as a stock bonus from the issuer on 04/01/2025. The sale is to be executed through Merrill Lynch in San Francisco for an aggregate market value of $4,502,400, with an approximate sale date of 08/12/2025 on NASDAQ. The filing lists 6,902,975 shares outstanding, so the 30,000-share notice represents roughly 0.43% of outstanding stock.
The filing also discloses recent dispositions by Charles F Willis IV: 8,750 shares sold on 06/03/2025 for $1,208,076.27 and 11,250 shares sold on 06/04/2025 for $1,529,382.78 (total 20,000 shares, proceeds $2,737,459.05). The notice includes the standard certification that the seller has no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans to sell 30,000 shares (≈$4.5M); size is small relative to float and likely not material to valuation.
The Form 144 shows a proposed sale of 30,000 shares acquired as a stock bonus on 04/01/2025, to be transacted via Merrill Lynch for an aggregate value of $4,502,400. Relative to 6,902,975 shares outstanding, the notice represents about 0.43% of the company. Recent June sales by Charles F Willis IV total 20,000 shares for roughly $2.74M. From a market-impact perspective, these volumes are modest and should not materially affect liquidity or share price absent other news.
TL;DR: Insider selling after receiving a stock bonus raises governance/market-interest questions but is not large enough to be immediately concerning.
The filer received the securities as a stock bonus (compensation) on 04/01/2025 and now intends to sell the full bonus amount. While insider sales can signal personal liquidity needs or portfolio rebalancing, the amounts disclosed—combined prior June sales and the proposed transaction total 50,000 shares—represent less than 1% of outstanding shares. The filing includes the standard certification denying undisclosed material adverse information.